Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study

BACKGROUND: This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOL...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitagawa, Yusuke, Osumi, Hiroki, Shinozaki, Eiji, Ota, Yumiko, Nakayama, Izuma, Suzuki, Takeshi, Wakatsuki, Takeru, Ogura, Mariko, Ooki, Akira, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189469/
https://www.ncbi.nlm.nih.gov/pubmed/32345249
http://dx.doi.org/10.1186/s12885-020-06864-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189469/
https://www.ncbi.nlm.nih.gov/pubmed/32345249
http://dx.doi.org/10.1186/s12885-020-06864-8

Ejemplares similares